Q-omics provides the consensus-scored LINC02210 profile across patient tissues and cancer cell-line models. LINC02210 expression is associated with patient survival in 24 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, LINC02210 is differentially expressed in 14, with the highest sampling consensus in KIRP. Additionally, LINC02210 RNA expression shows 21,570 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight ACC, KIRP, and LSCC as cancer lineages where LINC02210 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02210 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02210 survival associations across molecular data types. LINC02210 RNA expression shows survival associations in the most cancer types (24). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02210 RNA expression–survival associations across cancer types. High LINC02210 expression shows unfavorable associations in ACC, KICH, OV, KIRP, COAD and LIHC. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for LINC02210 RNA expression.
This table summarizes LINC02210 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 14. The strongest signals are observed in KIRP for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02210. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02210 shows lower tumor expression in THCA and KICH and higher tumor expression in KIRP, COAD, LUSC and CHOL. The KIRP box plot shows higher LINC02210 RNA expression in tumor versus normal tissue (log2 FC = +0.769, t-test p < 0.001).
This table shows molecular features associated with LINC02210 in patient tissues and cancer cell lines. In patient samples, LINC02210 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set.
